medroxyprogesterone has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altinoz, MA; Del Maestro, RF; Elmaci, I; Emin Ozcan, M; Nalbantoglu, J; Ozpinar, A | 1 |
| Altinoz, MA; Bilir, A; Elmaci, İ; Ozpinar, A | 1 |
2 other study(ies) available for medroxyprogesterone and Astrocytoma, Grade IV
| Article | Year |
|---|---|
From epidemiology and neurodevelopment to antineoplasticity. Medroxyprogesterone reduces human glial tumor growth in vitro and C6 glioma in rat brain in vivo.
Topics: Animals; Brain; Brain Neoplasms; Cerebellar Neoplasms; Dexamethasone; Disease Models, Animal; Glioblastoma; Glioma; Humans; Medroxyprogesterone; Meningioma; Rats; Tumor Cells, Cultured | 2018 |
Medroxyprogesterone effects on colony growth, autophagy and mitochondria of C6 glioma cells are augmented with tibolone and temozolomide: Cell kinetic and electron microscopical studies with a broad review of the literature.
Topics: Autophagy; Brain Neoplasms; Glioblastoma; Glioma; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron; Mitochondria; Temozolomide | 2019 |